Infusive Asset Management Inc. Decreases Stake in Colgate-Palmolive Company $CL

Key Points

• Infusive Asset Management Inc. has reduced its stake in Colgate-Palmolive by 20.2%, holding 61,965 shares after selling 15,650 shares in the first quarter.
• Several other institutional investors have increased their positions in Colgate-Palmolive, with Westend Capital Management and Cornerstone Planning Group notably boosting their holdings by 111.1% and 1,913.3% respectively during the same period.
• Analysts have decreased their price targets for Colgate-Palmolive, with average targets now ranging from $87.00 to $106.00, indicating a general adjustment in market sentiment.

Infusive Asset Management Inc. lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 20.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 61,965 shares of the company's stock after selling 15,650 shares during the period. Colgate-Palmolive accounts for 2.7% of Infusive Asset Management Inc.'s holdings, making the stock its 14th biggest holding. Infusive Asset Management Inc.'s holdings in Colgate-Palmolive were worth $5,806,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Westend Capital Management LLC increased its position in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 140 shares in the last quarter. Cornerstone Planning Group LLC boosted its stake in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after acquiring an additional 287 shares during the last quarter. Saudi Central Bank purchased a new position in Colgate-Palmolive in the first quarter valued at about $29,000. Vermillion Wealth Management Inc. purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $31,000. Finally, Bernard Wealth Management Corp. purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $36,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of CL traded up $1.46 during mid-day trading on Friday, reaching $85.13. The stock had a trading volume of 6,165,415 shares, compared to its average volume of 4,512,389. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a market cap of $68.80 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 4.43 and a beta of 0.35. The business has a fifty day moving average of $86.74 and a 200 day moving average of $89.77. Colgate-Palmolive Company has a 12 month low of $82.40 and a 12 month high of $109.04.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company's revenue for the quarter was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 EPS. Equities analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. UBS Group decreased their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Barclays increased their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a report on Tuesday, July 15th. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research report on Monday, August 4th. Citigroup dropped their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.